Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 2, 2011, Pages 173-179

  Diehl, Philipp ^a   Aleker, Miriam ^a   Helbing, Thomas ^a   Sossong, Verena ^a   Germann, Martin ^a   Sorichter, Stephan ^a   Bode, Christoph ^a   Moser, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cell activation; Microparticles; Pulmonary hypertension; Vascular inflammation

Indexed keywords

CD11B ANTIGEN; CD31 ANTIGEN; CD61 ANTIGEN;

AGED; ARTICLE; BLOOD CLOTTING; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE MICROPARTICLE; MALE; PLATELET MICROPARTICLE; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOEMBOLISM;

ADULT; AGED; BLOOD COAGULATION; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERTENSION, PULMONARY; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET COUNT; THROMBOEMBOLISM; VASCULITIS;

EID: 79951721396     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0507-z     Document Type: Article

References (38)

1. L Long A Crosby X Yang M Southwood PD Upton DK Kim NW Morrell 2009 Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease Circulation 119 566 576 1:CAS:528:DC%2BD1MXpt1eksQ%3D%3D 10.1161/CIRCULATIONAHA.108.821504 19153267
2. S Eddahibi N Morrell MP d'Ortho R Naeije S Adnot 2002 Pathobiology of pulmonary arterial hypertension Eur Respir J 20 1559 1572 1:STN:280: DC%2BD38jktVajtw%3D%3D 10.1183/09031936.02.00081302 12503718 (Pubitemid 35460627)
3. A Giaid M Yanagisawa D Langleben RP Michel R Levy H Shennib S Kimura T Masaki WP Duguid DJ Stewart 1993 Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1732 1739 1:STN:280:DyaK3s3mvVensA%3D%3D 10.1056/NEJM199306173282402 8497283 (Pubitemid 23170122)
4. M Humbert O Sitbon A Chaouat M Bertocchi G Habib V Gressin A Yaici E Weitzenblum JF Cordier F Chabot C Dromer C Pison M Reynaud-Gaubert A Haloun M Laurent E Hachulla G Simonneau 2006 Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 1023 1030 10.1164/rccm.200510-1668OC 16456139
5. T Thenappan SJ Shah S Rich M Gomberg-Maitland 2007 A USA-based registry for pulmonary arterial hypertension: 1982-2006 Eur Respir J 30 1103 1110 1:STN:280:DC%2BD2sjhs1aisg%3D%3D 10.1183/09031936.00042107 17804449 (Pubitemid 351194756)
6. GE D'Alonzo RJ Barst SM Ayres EH Bergofsky BH Brundage KM Detre AP Fishman RM Goldring BM Groves JT Kernis, et al. 1991 Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med 115 343 349 1863023
7. B Hugel MC Martinez C Kunzelmann JM Freyssinet 2005 Membrane microparticles: two sides of the coin Physiology (Bethesda) 20 22 27 1:CAS:528:DC%2BD2MXhslKru70%3D (Pubitemid 40363367)
8. L Burnier P Fontana BR Kwak A Angelillo-Scherrer 2009 Cell-derived microparticles in haemostasis and vascular medicine Thromb Haemost 101 439 451 1:CAS:528:DC%2BD1MXjslSnt7w%3D 19277403
9. O Morel F Toti B Hugel B Bakouboula L Camoin-Jau F Dignat-George JM Freyssinet 2006 Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26 2594 2604 1:CAS:528: DC%2BD28XhtFymt7jP 10.1161/01.ATV.0000246775.14471.26 16990554
10. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327:580-583
11. P Diehl F Nagy V Sossong T Helbing F Beyersdorf M Olschewski C Bode M Moser 2008 Increased levels of circulating microparticles in patients with severe aortic valve stenosis Thromb Haemost 99 711 719 1:CAS:528: DC%2BD1cXlsF2gtrY%3D 18392329 (Pubitemid 351694227)
12. Diehl P, Aleker M, Helbing T, Sossong V, Beyersdorf F, Olschewski M, Bode C, Moser M Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation. Interact Cardiovasc Thorac Surg. 11:133-137
13. JF Keuren EJ Magdeleyns JW Govers-Riemslag T Lindhout J Curvers 2006 Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation Br J Haematol 134 307 313 1:CAS:528:DC%2BD28XosFCisr8%3D 10.1111/j.1365-2141.2006.06167.x 16848773 (Pubitemid 43990792)
14. H Ogura T Kawasaki H Tanaka T Koh R Tanaka Y Ozeki H Hosotsubo Y Kuwagata T Shimazu H Sugimoto 2001 Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis J Trauma 50 801 809 1:CAS:528:DC%2BD3MXktF2qsrg%3D 10.1097/00005373-200105000-00005 11371835 (Pubitemid 32499602)
15. LL Horstman W Jy JJ Jimenez C Bidot YS Ahn 2004 New horizons in the analysis of circulating cell-derived microparticles Keio J Med 53 210 230 1:CAS:528:DC%2BD2MXhvFyqsbg%3D 10.2302/kjm.53.210 15647627 (Pubitemid 40139594)
16. RM Tuder CD Cool M Yeager L Taraseviciene-Stewart TM Bull NF Voelkel 2001 The pathobiology of pulmonary hypertension Endothelium. Clin Chest Med 22 405 418 1:STN:280:DC%2BD3MrktlWqtA%3D%3D 10.1016/S0272-5231(05)70280-X (Pubitemid 32916102)
17. P Herve M Humbert O Sitbon F Parent H Nunes C Legal G Garcia G Simonneau 2001 Pathobiology of pulmonary hypertension. The role of platelets and thrombosis Clin Chest Med 22 451 458 1:STN:280:DC%2BD3MrktlWquw%3D%3D 10.1016/S0272-5231(05)70283-5 11590840 (Pubitemid 32912078)
18. S Eddahibi M Humbert S Sediame C Chouaid C Partovian B Maitre E Teiger D Rideau G Simonneau O Sitbon S Adnot 2000 Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy Am J Respir Crit Care Med 162 1493 1499 1:STN:280:DC%2BD3M%2Fis1SgsA%3D%3D 11029367
19. Ulrich S, Huber LC, Fischler M, Treder U, Maggiorini M, Eberli FR, Speich R (2010) Platelet serotonin content and transpulmonary platelet serotonin gradient in patients with pulmonary hypertension. Respiration, doi: 10.1159/000314271
20. JK Damas K Otterdal A Yndestad H Aass NO Solum SS Froland S Simonsen P Aukrust AK Andreassen 2004 Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells Circulation 110 999 1005 1:CAS:528:DC%2BD2cXms1OgtL4%3D 10.1161/01.CIR.0000139859.68513.FC 15302794 (Pubitemid 39136216)
21. F Sakamaki S Kyotani N Nagaya N Sato H Oya T Satoh N Nakanishi 2000 Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy Circulation 102 2720 2725 1:CAS:528:DC%2BD3cXptVSjtL8%3D 11094038
22. EI Sinauridze DA Kireev NY Popenko AV Pichugin MA Panteleev OV Krymskaya FI Ataullakhanov 2007 Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets Thromb Haemost 97 425 434 1:CAS:528:DC%2BD2sXkvVSgurk%3D 17334510 (Pubitemid 46437805)
23. Bal L, Ederhy S, Di Angelantonio E, Toti F, Zobairi F, Dufaitre G, Meuleman C, Mallat Z, Boccara F, Tedgui A, Freyssinet JM, Cohen A (in press) Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study. Int J Cardiol. doi: 10.1016/j.ijcard.2009.11.048
24. D Collen MF Hoylaerts 2005 Relationship between inflammation and venous thromboembolism as studied by microparticle assessment in plasma J Am Coll Cardiol 45 1472 1473 10.1016/j.jacc.2005.02.029 15862421 (Pubitemid 40615621)
25. SL Pfister 2004 Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery Hypertension 43 428 433 1:CAS:528:DC%2BD2cXitVajtrw%3D 10.1161/01.HYP.0000110906.77479.91 14718367 (Pubitemid 38174150)
26. R Pakala 2004 Serotonin and thromboxane A2 stimulate platelet-derived microparticle-induced smooth muscle cell proliferation Cardiovasc Radiat Med 5 20 26 10.1016/j.carrad.2003.12.002 15275628 (Pubitemid 38953358)
27. M Katayama M Handa Y Araki H Ambo Y Kawai K Watanabe Y Ikeda 1993 Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome Br J Haematol 84 702 710 1:STN:280:DyaK2c%2FjtFygsw%3D%3D 10.1111/j.1365-2141.1993.tb03149.x 7692937 (Pubitemid 23248065)
28. T Minamino H Christou CM Hsieh Y Liu V Dhawan NG Abraham MA Perrella SA Mitsialis S Kourembanas 2001 Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia Proc Natl Acad Sci USA 98 8798 8803 1:CAS:528:DC%2BD3MXls1WitbY%3D 10.1073/pnas.161272598 11447290 (Pubitemid 32678107)
29. Hall SM, Brogan P, Haworth SG, Klein N (2010) Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children. Thorax, doi: 10.1136/thx.2008.106435
30. N Amabile C Heiss WM Real P Minasi D McGlothlin EJ Rame W Grossman T De Marco Y Yeghiazarians 2008 Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension Am J Respir Crit Care Med 177 1268 1275 1:CAS:528:DC%2BD1cXns1KgsL8%3D 10.1164/rccm.200710-1458OC 18310479 (Pubitemid 351860937)
31. PM Hassoun L Mouthon JA Barbera S Eddahibi SC Flores F Grimminger PL Jones ML Maitland ED Michelakis NW Morrell JH Newman M Rabinovitch R Schermuly KR Stenmark NF Voelkel JX Yuan M Humbert 2009 Inflammation, growth factors, and pulmonary vascular remodeling J Am Coll Cardiol 54 S10 S19 1:CAS:528: DC%2BC3cXkvVOks7o%3D 10.1016/j.jacc.2009.04.006 19555853
32. RJ Cody GJ Haas PF Binkley Q Capers R Kelley 1992 Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure Circulation 85 504 509 1:STN:280:DyaK387js1Giuw%3D%3D 1735147
33. RP Weerackody DJ Welsh RM Wadsworth AJ Peacock 2009 Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction Am J Physiol Heart Circ Physiol 296 H1312 H1320 1:CAS:528:DC%2BD1MXlvFagurs%3D 10.1152/ajpheart.00977.2008 19201999
34. Z Ghorishi JM Milstein FR Poulain A Moon-Grady T Tacy SH Bennett JR Fineman MW Eldridge 2007 Shear stress paradigm for perinatal fractal arterial network remodeling in lambs with pulmonary hypertension and increased pulmonary blood flow Am J Physiol Heart Circ Physiol 292 H3006 H3018 1:CAS:528: DC%2BD2sXmvF2ks7g%3D 10.1152/ajpheart.01012.2006 17308003 (Pubitemid 47084553)
35. B Bakouboula O Morel A Faure F Zobairi L Jesel A Trinh M Zupan M Canuet L Grunebaum A Brunette D Desprez F Chabot E Weitzenblum JM Freyssinet A Chaouat F Toti 2008 Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension Am J Respir Crit Care Med 177 536 543 1:CAS:528:DC%2BD1cXjvFyqs70%3D 10.1164/rccm.200706-840OC 18006886 (Pubitemid 351442193)
36. TM Bull H Golpon RP Hebbel A Solovey CD Cool RM Tuder MW Geraci NF Voelkel 2003 Circulating endothelial cells in pulmonary hypertension Thromb Haemost 90 698 703 1:CAS:528:DC%2BD3sXot1ymsrg%3D 14515191 (Pubitemid 37287638)
37. DB Klinkner JC Densmore S Kaul L Noll HJ Lim D Weihrauch KA Pritchard Jr KT Oldham TL Sander 2006 Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function Shock 25 575 580 1:CAS:528: DC%2BD28XlvVenu7s%3D 10.1097/01.shk.0000209558.69575.80 16721264 (Pubitemid 44297017)
38. V Fuster PM Steele WD Edwards BJ Gersh MD McGoon RL Frye 1984 Primary pulmonary hypertension: natural history and the importance of thrombosis Circulation 70 580 587 1:STN:280:DyaL2M%2Fgt1aitQ%3D%3D 6148159 (Pubitemid 14020655)